Nutrient-sensing mTORC1: Integration of metabolic and autophagic signals - Journal of Molecular and Cellular Cardiology
Biomedicines | Free Full-Text | Different HSP90 Inhibitors Exert Divergent Effect on Myxoid Liposarcoma In Vitro and In Vivo | HTML
Frontiers | Interplay Between Calcium and AMPK Signaling in Human Cytomegalovirus Infection
Polysaccharide-Based Theranostic Systems for Combined Imaging and Cancer Therapy: Recent Advances and Challenges | ACS Biomaterials Science & Engineering
Obesity and cancer, a case for insulin signaling | Cell Death & Disease
.jpg?mode=max "Christoph Voll (1897-1939)")
Christoph Voll (1897-1939)
microRNA‐103a Functions as a Mechanosensitive microRNA to Inhibit Bone Formation Through Targeting Runx2 - Zuo - 2015 - Journal of Bone and Mineral Research - Wiley Online Library
Frontiers | Regulation of CD4+ T Cell Signaling and Immunological Synapse by Protein Tyrosine Phosphatases: Molecular Mechanisms in Autoimmunity
Genomics in acute lymphoblastic leukaemia: insights and treatment implications | Nature Reviews Clinical Oncology
Drug repositioning in cancer: The current situation in Japan - Masuda - 2020 - Cancer Science - Wiley Online Library
Differential effects of AMPK agonists on cell growth and metabolism | Oncogene
Hyperactive Akt-mTOR pathway as a therapeutic target for pain hypersensitivity in Cntnap2-deficient mice - ScienceDirect
Cancers | Free Full-Text | Molecular and Cellular Mechanisms of Metformin in Cervical Cancer | HTML
The role of selenium in cell survival and its correlation with protective effects against cardiovascular disease: A literature review - ScienceDirect
The effects of biophysical stimulation on osteogenic differentiation and the mechanisms from ncRNAs - Mao - 2021 - Cell Biochemistry and Function - Wiley Online Library
Inhibition of Polo-like Kinase 1 (Plk1) Enhances the Antineoplastic Activity of Metformin in Prostate Cancer* - Journal of Biological Chemistry
Frontiers | Targeting Phosphatases and Kinases: How to Checkmate Cancer
MUL1 E3 ligase regulates the antitumor effects of metformin in chemoresistant ovarian cancer cells via AKT degradation
Lead toxicity: a review
mTOR: a pharmacologic target for autophagy regulation - Document - Gale OneFile: Health and Medicine
HUMAN PANCREATIC CANCER CELLS UNDERGO PROFOUND METABOLIC REPROGRAMMING TOWARDS CELLULAR STEMNESS AS ADAPTATION TO INHIBITION OF THE AKT PATHWAY | bioRxiv
Central role of Yes-associated protein and WW-domain-containing transcriptional co-activator with PDZ-binding motif in pancreatic cancer development
Hydrazonoyl chlorides possess promising antitumor properties - ScienceDirect
Advances in metformin‑based metabolic therapy for non‑small cell lung cancer (Review)
Slow Aging and Delay Chronic Disease Development | William H Bestermann Jr MD | Substack
